I saw that story and was very excited. Even though the study wasn't that thorough and was very short-term, the big news for me is that it involved an existing, already approved drug, not some experimental drug years away (if ever) from approval. I haven't seen anything like this in the 2+ years that I have been following MG. Hopefully his study will continue and we'll get to see what the long-term results are.